Ardelyx (ARDX) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,178.57% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 11.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.76% |
| Dec 31, 2025 | -150.00% |
| Jun 30, 2025 | -14.29% |
| Mar 31, 2025 | -54.55% |
| Dec 31, 2024 | 115.38% |
| Sep 30, 2024 | -111.43% |
| Jun 30, 2024 | 12.50% |
| Mar 31, 2024 | 15.38% |
| Dec 31, 2023 | -218.18% |
| Sep 30, 2023 | 121.43% |
| Jun 30, 2023 | 57.89% |
| Mar 31, 2023 | 38.10% |
| Dec 31, 2022 | 135.48% |
| Sep 30, 2022 | 66.67% |
| Jun 30, 2022 | 57.78% |
| Mar 31, 2022 | 38.24% |
| Dec 31, 2021 | 3.13% |
| Sep 30, 2021 | -110.00% |
| Jun 30, 2021 | -60.71% |
| Mar 31, 2021 | -36.00% |
| Dec 31, 2020 | -4.26% |
| Jun 30, 2016 | -297.62% |
| Jun 30, 2015 | 133.33% |
| Mar 31, 2015 | 92.21% |
| Jun 30, 2014 | 122.22% |